68Ga-DOTA-FAPI

DRUG2 trials

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Zhongnan Hospital

Conditions

FAPIMalignant NeoplasmOral CancerPET/CT

Unknown Phase

Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant Tumors

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyMalignant Neoplasm

Start: 2020-05-22End: 2023-12-31Target: 500Updated: 2023-02-14

Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma

RecruitingNCT05030597

Zhongnan HospitalFAPI, Oral Cancer, PET/CT

Start: 2021-09-15End: 2025-12-31Target: 100Updated: 2025-05-28

Related Papers

Predictive value of [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT on pathologic response to neoadjuvant chemoimmunotherapy for locally advanced resectable oral squamous cell carcinoma.

2025-06-231 citations

Gallium-68-labeled fibroblast activation protein inhibitor PET in gastrointestinal cancer: insights into diagnosis and management.

2022-06-0319 citations

Increased uptake of <sup>68</sup>Ga-DOTA-FAPI-04 in bones and joints: metastases and beyond.

2021-07-0939 citations

A head-to-head comparison of <sup>68</sup>Ga-DOTA-FAPI-04 and <sup>18</sup>F-FDG PET/MR in patients with nasopharyngeal carcinoma: a prospective study.

2021-02-2073 citations

Non-malignant findings of focal <sup>68</sup>Ga-FAPI-04 uptake in pancreas.

2021-01-1541 citations